Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
4.900
-0.140 (-2.78%)
Nov 4, 2025, 4:00 PM EST - Market closed
Puma Biotechnology Revenue
Puma Biotechnology had revenue of $52.44M in the quarter ending June 30, 2025, with 11.37% growth. This brings the company's revenue in the last twelve months to $238.06M, up 8.63% year-over-year. In the year 2024, Puma Biotechnology had annual revenue of $230.47M, down -2.19%.
Revenue (ttm)
$238.06M
Revenue Growth
+8.63%
P/S Ratio
1.02
Revenue / Employee
$1,384,081
Employees
172
Market Cap
246.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 230.47M | -5.17M | -2.19% |
| Dec 31, 2023 | 235.64M | 7.61M | 3.34% |
| Dec 31, 2022 | 228.03M | -25.12M | -9.92% |
| Dec 31, 2021 | 253.16M | 28.05M | 12.46% |
| Dec 31, 2020 | 225.11M | -47.15M | -17.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
PBYI News
- 12 days ago - Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results - Business Wire
- 4 weeks ago - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Puma Biotechnology to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Business Wire
- 3 months ago - Puma Biotechnology, Inc. (PBYI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Puma Biotechnology Reports Second Quarter Financial Results - Business Wire
- 3 months ago - Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2025 Financial Results - Business Wire
- 4 months ago - Puma Biotechnology: Updated Timelines And A Resurgence In Sentiment - Seeking Alpha
- 6 months ago - Puma Biotechnology, Inc. (PBYI) Q1 2025 Earnings Call Transcript - Seeking Alpha